KRAS and neoplasm: We first used Connectivity Map (CMap) dataset to identify compounds for which the gene expression patterns were opposite the KRAS subtype-specific expression patterns (i.e., gene expression was increased in KM1 or KM2 subtype tumor tissues but decreased after treatment with the compound).